These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 232975)

  • 1. [Effect of silica on the anti-tumour activity of "Corynebacterium parvum" (author's transl)].
    Mazurek C; Stiffel C; Chalvet H; Biozzi G
    Ann Immunol (Paris); 1979; 130(6):815-26. PubMed ID: 232975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antitumor effect of Corynebacterium parvum].
    Mazurek C; Chalvet H; Biozzi G; Stiffel C
    Ann Immunol (Paris); 1977; 128(1-2):161-3. PubMed ID: 576780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Passive transfer of "Corynebacterium parvum" anti-tumour protection by stimulated peritoneal cells ].
    Mazurek C; Stiffel C; Chalvet H; Biozzi G
    Ann Immunol (Paris); 1981; 132D(1):43-54. PubMed ID: 6896973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of the age of the mouse on the action of Corynebacterium parvum in inhibiting the growth of 2 syngenetic tumors].
    Mazureka C; Stiffel C; Chalvet H; Biozzi G
    C R Seances Acad Sci III; 1981 Oct; 293(4):225-8. PubMed ID: 6794870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection by polyI:polyC against infection with herpes simplex virus in mice pretreated with Corynebacterium parvum.
    Storch E; Baumgartl D; Kirchner H
    Nat Immun Cell Growth Regul; 1983-1984; 3(3):134-42. PubMed ID: 6209572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Corynebacterium parvum treatment and Toxoplasma gondii infection on macrophage-mediated cytostasis of tumour target cells.
    Krahenbuhl JL; Lambert LH; Remington JS
    Immunology; 1976 Dec; 31(6):837-46. PubMed ID: 992714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the mechanism of Corynebacterium parvum anti-tumour activity. I. Protective effect on the growth of two syngeneic tumours.
    Mazurek C; Chalvet H; Stiffel CL; Biozzi G
    Int J Cancer; 1976 Apr; 17(4):511-7. PubMed ID: 946965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antitumoral activity of various doses of corynebacterium parvum as a function of the age of mice].
    Stiffel C; Chalvet H; Mazurek C
    Ann Inst Pasteur Immunol (1985); 1985; 136D(1):19-27. PubMed ID: 3840664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Corynebacterium parvum on the class and subclass of antibody produced in the response of different strains of mice to sheep erythrocytes.
    Warr GW; James K
    Immunology; 1975 Mar; 28(3):431-42. PubMed ID: 1092609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active experimental inhibition of cancer by corynebacterium parvum.
    Wrba H; Dutter A
    Osterr Z Onkol; 1977 Oct; 4(2-3):60-1. PubMed ID: 579449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action of C. parvum on a solid, subcutaneous mouse tumour.
    Jones PD; Sadler TE; Castro JE
    Dev Biol Stand; 1977 Apr 13-15; 38():259-64. PubMed ID: 204533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of C. parvum on intratumor immunity to the T1699 mammary adenocarcinoma.
    Haskill S; Ritter F; Becker S
    J Immunol; 1980 Jul; 125(1):454-8. PubMed ID: 6247400
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in syngeneic tumor-bearing mice.
    Wolmark N; Fisher B
    Cancer Res; 1974 Nov; 34(11):2869-72. PubMed ID: 4419513
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of adriamycin and Corynebacterium parvum in tumor-bearing mice: modulation of response to sheep red blood cells.
    Dimitrov NV; Denny TN; Weisman MF; Cameron DG
    J Natl Cancer Inst; 1979 Aug; 63(2):423-6. PubMed ID: 379400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of macrophages in the adjuvant effect on antibody production of Corynebacterium parvum.
    Watson SR; Sljivić VS
    Clin Exp Immunol; 1976 Jan; 23(1):149-53. PubMed ID: 770033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. IX. Macrophage content of tumors in mice.
    Gebhardt MC; Fisher B
    J Natl Cancer Inst; 1979 Apr; 62(4):1035-41. PubMed ID: 285276
    [No Abstract]   [Full Text] [Related]  

  • 17. Suppressive effects of Corynebacterium parvum on primary and secondary antibody responses in mice.
    Ansell JD; Trail KN; McDougall CM; Inchley CJ
    J Reticuloendothel Soc; 1983 Oct; 34(4):311-21. PubMed ID: 6620257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour growth, phagocytic activity and antibody response in Corynebacterium parvum-treated mice.
    Woodruff MF; McBride WH; Dunbar N
    Clin Exp Immunol; 1974 Jul; 17(3):509-18. PubMed ID: 4549691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulation by Corynebacterium parvum. 1. Variable effects on anti-sheep erythrocyte antibody responses.
    Ghaffar A; Sigel MM
    Immunology; 1978 Nov; 35(5):685-93. PubMed ID: 363603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of lymphocyte proliferation and antibody production in vitro by silica, talc, bentonite or Corynebacterium parvum: involvement of peroxidative processes.
    Hoffeld JT
    Eur J Immunol; 1983 May; 13(5):364-9. PubMed ID: 6303797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.